You have no items in your shopping cart.
Search results for: 'antigen'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.6 KDa. Observed: 60-90 KDa, reducing conditions
Mouse
Glu22-Lys236
C-Fc
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.3 KDa. Observed: 58-75 KDa, reducing conditions
Mouse
Leu28-Arg183
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 58.1 KDa. Observed: 80-110 KDa, reducing conditions
Human
Cys24-Glu540
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 48.9 KDa. Observed: 60-80 KDa, reducing conditions
Human
Glu22-Cys213
C-Fc
50 μg, 10 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.8 KDa. Observed: 35-44 KDa, reducing conditions
Human
Glu22-Cys213
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45.96 KDa. Observed: 41-50 KDa, reducing conditions
Human
Met1-Pro390
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.8 KDa. Observed: 45-55 KDa, reducing conditions
Human
Gly21-Ser162
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44 KDa. Observed: 55-75 KDa, reducing conditions
Human
Leu24-Gln186
C-Fc-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.7 KDa. Observed: 30-45 KDa, reducing conditions
Mouse
Asp18-Glu240(Gly236Arg)
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 102.3 KDa. Observed: 120-150 KDa, reducing conditions
Human
Asp20-Arg687
C-Fc
10 μg, 50 μg, 500 μg, 1 mg
